From: Quality of life of patients with ADPKD—Toranomon PKD QOL study: cross-sectional study
I | II | III | IV | V | |
---|---|---|---|---|---|
PCS | 0.360 | 0.633 | 0.052 | 0.046 | −0.059 |
Q1 | −0.065 | 0.825 | −0.012 | 0.041 | −0.082 |
Q2 | −0.045 | 0.847 | 0.135 | −0.054 | −0.006 |
Q3 | 0.739 | 0.273 | −0.086 | 0.064 | 0.113 |
Q4 | 0.757 | −0.122 | 0.191 | −0.226 | −0.112 |
Q5 | 0.843 | −0.082 | −0.309 | 0.015 | −0.048 |
Q6 | 0.129 | −0.109 | −0.001 | 0.728 | 0.229 |
Q7 | 0.192 | 0.053 | 0.584 | −0.124 | 0.024 |
Q8 | 0.007 | −0.162 | 0.261 | 0.083 | 0.632 |
Q9 | −0.214 | 0.145 | −0.076 | 0.797 | −0.176 |
Q10 | 0.051 | −0.006 | 0.132 | 0.033 | −0.805 |
Q11 | −0.328 | 0.149 | 0.915 | 0.001 | 0.057 |
Q12 | 0.327 | −0.269 | 0.380 | 0.290 | −0.198 |
pain | −0.495 | −0.287 | −0.127 | −0.076 | −0.127 |
Inter-factor correlations | |||||
I | - | 0.225 | 0.424 | 0.206 | 0.037 |
II | 0.225 | - | 0.159 | 0.095 | −0.024 |
III | 0.424 | 0.159 | - | 0.173 | 0.025 |
IV | 0.206 | 0.095 | 0.173 | - | −0.074 |
V | 0.037 | −0.024 | 0.025 | −0.074 | - |